CAPIRI regimen
Term · Oncology and biomedicine · MLC-T-ONC-001390
An abbreviation for a chemotherapy combination used to treat colorectal cancer that has spread to other parts of the body. It is also used to treat esophageal cancer and stomach cancer that are advanced or have spread to other parts of the body. It includes the drugs capecitabine (Xeloda) and irinotecan hydrochloride. Also called CAPIRI, XELIRI, and XELIRI regimen.
| Identifier | MLC-T-ONC-001390 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | CAPIRI; XELIRI; XELIRI regimen |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-001390",
"term": "CAPIRI regimen",
"field": "Oncology and biomedicine",
"definition": "An abbreviation for a chemotherapy combination used to treat colorectal cancer that has spread to other parts of the body. It is also used to treat esophageal cancer and stomach cancer that are advanced or have spread to other parts of the body. It includes the drugs capecitabine (Xeloda) and irinotecan hydrochloride. Also called CAPIRI, XELIRI, and XELIRI regimen.",
"synonyms": [
"CAPIRI",
"XELIRI",
"XELIRI regimen"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/capiri-regimen/"
}
Record 4,113 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.